Moureletou Roza Panagis, Kalliouris Dimitrios, Manesis Konstantinos, Theodoroleas Sotirios, Bistaraki Angeliki, Boubousis George, Nikou Efstathios
2nd Department of General Surgery, 417 Army Share Fund Hospital, Athens, Greece.
Surgery Department, 417 Army Share Fund Hospital, Athens, Greece.
Surg J (N Y). 2020 Dec 14;6(4):e175-e179. doi: 10.1055/s-0040-1718699. eCollection 2020 Oct.
Central pancreatectomy (CP), a partial resection of the pancreas, is indicated for the excision of neuroendocrine tumors (NETs) of the pancreas, when located at the neck or the proximal body. Specifically, CP is preferable in functional NET and in nonfunctional sized 1 to 2 cm or/with proliferation marker Ki67 < 20% (Grade I/II). Postoperative leakage from the remaining pancreas constitutes the most frequent complication of CP (up to 63%). The aim of our study was to share the experience of our center in CP for NET, with pancreaticojejunal anastomosis. In 1 year, we performed CP in two patients, following the aforementioned criteria. They presented with tumor of the body of the pancreas, which was found in random check with computed tomography, with negative hormonal blood tests and they underwent magnetic resonance imaging and endoscopic ultrasound/fine-needle biopsy/pathological examination. The patients underwent CP with Roux-en-Y pancreaticojejunal anastomosis of the distal pancreatic stump and jejunal patch of the proximal pancreatic stump. Histological exam revealed NET sized 2.8 cm and 1.45 cm, Grade I and II, respectively. Postoperatively both patients developed small pancreatic leakage, which did not affect their physical condition and stopped after 20 and 30 days. No one needed pancreatic enzymes supplements or developed new-onset diabetes mellitus. CP provided adequate, functional remaining pancreatic tissue in both patients. Small leakages were treated conservatively and retreated without septic complications. As a result, CP might be considered as safe and effective technique for pancreatic neck/proximal body NET.
胰体尾切除术(CP)是胰腺的部分切除术,适用于切除位于胰腺颈部或胰体近端的神经内分泌肿瘤(NETs)。具体而言,CP在功能性NET以及大小为1至2厘米或/和增殖标志物Ki67<20%(I/II级)的无功能性NET中更为适用。剩余胰腺的术后渗漏是CP最常见的并发症(高达63%)。我们研究的目的是分享我们中心在采用胰空肠吻合术进行胰体尾切除术治疗NET方面的经验。
在1年时间里,我们按照上述标准对两名患者实施了CP。他们均表现为胰体部肿瘤,通过计算机断层扫描随机检查发现,血液激素检测呈阴性,随后接受了磁共振成像以及内镜超声/细针穿刺活检/病理检查。
患者接受了CP,采用Roux-en-Y胰空肠吻合术处理胰腺远端残端,近端胰腺残端采用空肠补片。组织学检查显示NET大小分别为2.8厘米和1.45厘米,分别为I级和II级。术后两名患者均出现了少量胰腺渗漏,但未影响其身体状况,分别在20天和30天后渗漏停止。无人需要补充胰酶或新发糖尿病。
CP为两名患者均提供了足够的、有功能的剩余胰腺组织。少量渗漏采用保守治疗,未出现感染并发症。因此,CP可被视为治疗胰腺颈部/胰体近端NET的一种安全有效的技术。